Clinical Research Directory
Browse clinical research sites, groups, and studies.
PREdiction of Chronic LUng Allograft Dysfunction
Sponsor: Nantes University Hospital
Summary
Chronic lung allograft dysfunction (CLAD) is the leading cause of long-term mortality after lung transplantation. Several risk factors for CLAD have been identified, but the exact pathophysiology and triggering molecular factors remain largely unknown. Moreover, in clinical practice, no integration of the different risk factors is achieved. CLAD is therefore diagnosed most often late with the persistent decline in respiratory function, revealing a profound and irreversible alteration of the pulmonary graft. Several blood biomarkers that can predict the occurrence of CLAD more than 6 months before clinical diagnosis have been identified and validated. From these preliminary results, a composite score is being developed from independent samples from the COLT (COhort in Lung Transplantation) cohort. The main objective of this project is to validate this robust and predictive composite score (biological and clinical) of CLAD.
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
240
Start Date
2020-09-10
Completion Date
2027-03
Last Updated
2025-05-16
Healthy Volunteers
No
Conditions
Locations (10)
CHU de Bordeaux
Bordeaux, France
CHU de Grenoble
Grenoble, France
Centre Chirurgical Marie Lannelongue
Le Plessis-Robinson, France
CHU de Lyon
Lyon, France
AP-HM
Marseille, France
CHU de Nantes
Nantes, France
Hôpital Bichat
Paris, France
CHRU de Strasbourg
Strasbourg, France
Hôpital Foch
Suresnes, France
CHU de Toulouse
Toulouse, France